COLLEEN HOPKINS: Open Payments
NPI 1447090519 · EDISON, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$290 in 9 payments from 5 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $290
Education: $164Food & beverage: $126
| Company | Payments | Amount |
|---|---|---|
| Gilead Sciences, Inc. | 2 | $164 |
| Merck Sharp & Dohme LLC | 3 | $49 |
| Incyte Corporation | 2 | $35 |
| GENZYME CORPORATION | 1 | $23 |
| ABBVIE INC. | 1 | $19 |
Products named: Trodelvy, KEYTRUDA, JAKAFI, WAYRILZ, VENCLEXTA.
Industry payments across NJ — which companies pay providers there.
